| Effect of Soluble Fiber on Hypertriglyceridemia and Immune Profile in HIV-positive Individuals. (NCT00540111) | UPECLIN HC FM Botucatu Unesp | 2005-03-01 |
| Interluekin-7 to Treat HIV-Infected People Receiving Antiretroviral Treatment (NCT00105417) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-03-01 |
| Safety and Efficacy of an Investigational Drug in Human Immunodeficiency Virus (HIV)-Infected Patients Failing Current Antiretroviral Therapies (0518-005)(COMPLETED) (NCT00105157) | Merck Sharp & Dohme LLC | 2005-03-01 |
| Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance (NCT00130286) | Weill Medical College of Cornell University | 2005-03-01 |
| Role of the Autonomic Nervous System in HIV-Lipodystrophy (NCT00149097) | Hannover Medical School | 2005-03-01 |
| Usage of Acyclovir for Suppression of HIV-1 and HSV-2 Coinfected Persons in Cameroon (NCT00209313) | Fred Hutchinson Cancer Center | 2005-03-01 |
| Improving HIV Screening With Nurse-Based Rapid Testing/Streamlined Counseling (NCT00119548) | US Department of Veterans Affairs | 2005-03-01 |
| Effects of Anti-HIV Therapy on Nervous System Function (NCT00432003) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-03-01 |
| Biomarkers of Insomnia and Fatigue in HIV/AIDS (Symptoms and Genetics Study) (NCT00503633) | University of California, San Francisco | 2005-03-01 |
| An Imaging Trial of the Distribution of Topical Gel Formulations in the Human Vagina (NCT00214747) | Biosyn | 2005-03-01 |
| Reasons for Non-treatment of Hepatitis C in HCV Mono-infected Patients Versus HCV-HIV Co-infected Patients in a University Setting (NCT00222859) | University of Pittsburgh | 2005-03-01 |
| Anti-D for Treating Thrombocytopenia in Adults Infected With Hepatitis C Virus With or Without HIV Co-Infection (NCT00239733) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-03-01 |
| Project UNITY - HIV Risk Reduction and Vaccine Education Interventions (NCT00150098) | New York Blood Center | 2005-02-01 |
| Helping HIV Infected Patients in South Africa Adhere to Drug Regimens (NCT00076804) | Johns Hopkins University | 2005-02-01 |
| The Effect of Low-Dose Human Growth Hormone Therapy in HIV Infected Patients (NCT00119769) | Hvidovre University Hospital | 2005-02-01 |
| Prevalence of HIV and Tuberculosis in Masiphumelele Township, Cape Town, South Africa (NCT00096681) | CIPRA SA | 2005-02-01 |
| Evaluate Tolerability of a Recombinant DNA HIV-1 Vaccine in Healthy Adults (NCT00187148) | St. Jude Children's Research Hospital | 2005-02-01 |
| Preventing Sexual Transmission of HIV With Anti-HIV Drugs (NCT00074581) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-02-01 |
| A Study of Anal Cancer Development in HIV Infected People (NCT00107679) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-02-01 |
| Strategies for Delivering Anti-HIV Therapy in South Africa (NCT00080522) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-02-01 |
| Mothers Living With HIV and Their Adolescent Children (NCT00988390) | University of California, Los Angeles | 2005-02-01 |
| HIV-1 Vaccine Booster in Previously Immunized Uninfected Adult Volunteers (NCT00102089) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-01-18 |
| Study To Evaluate Long Term Maintenance With TRIZIVIR After Boosted Protease Inhibitor (PI) Or Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) In HIV-1 Infected Adults (NCT00449436) | GlaxoSmithKline | 2005-01-10 |
| Effect of Leflunomide on T Cell Proliferation in HIV-Infected Patients (NCT00101374) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-01-05 |
| A Clinical Research Study Designed To Determine If Treatment of Hepatitis C With Milk Thistle is More Effective Than No Treatment In Patients Infected With Both HIV And Hepatitis C (NCT00246363) | Henry Sacks | 2005-01-01 |
| A Study to Evaluate of the Efficacy of Enfuvirtide During the Induction Phase of Therapy (NCT00344760) | University of Maryland, Baltimore | 2005-01-01 |
| Collection of Blood Samples From HIV Infected People (NCT00096772) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-01-01 |
| Evaluation of an Intervention on Adherence to Highly Active Antiretroviral Therapy (HAART) in HIV Infected Adults (NCT00203853) | University of Chicago | 2005-01-01 |
| BufferGel and PRO 2000/5: Vaginal Gels to Prevent HIV Infection in Women (NCT00074425) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-01-01 |
| A Study to Evaluate the Safety and Efficacy of an Investigational Drug in HIV Infected Patients (0518-004)(COMPLETED) (NCT00100048) | Merck Sharp & Dohme LLC | 2005-01-01 |
| Treatment of Acute HIV With Emtricitabine, Tenofovir and Efavirenz (CID 0805) (NCT00924898) | University of North Carolina, Chapel Hill | 2005-01-01 |
| Exercise and Pioglitazone for HIV-Metabolic Syndromes (NCT00639457) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2005-01-01 |
| HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1 Co-infected Persons (NCT00465205) | University of Washington | 2005-01-01 |
| Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIV (NCT00307502) | Germans Trias i Pujol Hospital | 2005-01-01 |
| Nine Month Course of Anti-HIV Medications for People Recently Infected With HIV (NCT00090779) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2005-01-01 |
| Computer-Generated Vs. Standard Informed Consent for HIV Research Studies (NCT00104559) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-01-01 |
| Three Generic Nevirapine-Based Antiretroviral Treatments in Chinese Patients:Multicentric Observation Cohort (NCT00618176) | Peking Union Medical College | 2005-01-01 |
| Effectiveness of Structured Ecosystems Therapy for Reducing HIV Risk Behaviors and Improving Treatment Adherence in HIV Infected Men Released From Prison (NCT00344591) | University of California, San Francisco | 2005-01-01 |
| The Switch Study: The Role of Lamivudine/Emtricitabine (3TC/FTC) in Antiretroviral Regimens (NCT00152061) | Stanford University | 2005-01-01 |
| Viral Dynamics and Pharmacokinetics of Abacavir and Tenofovir (NCT00214890) | University of California, San Diego | 2004-12-07 |
| One Month Dual Antiretroviral Prophylaxis to Prevent Resistance Mutations in Mothers Exposed to Single Dose Nevirapine (NCT00142337) | Institut de Recherche pour le Developpement | 2004-12-01 |
| Evaluate Weight Gain Using 2 Different Formulations of Megestrol Acetate Oral Suspension for AIDS-related Weight Loss (NCT00637572) | Endo USA Inc., a Keenova Therapeutics Company | 2004-12-01 |
| Effectiveness of Enhanced Counseling and Observed Therapy on Antiretroviral Adherence in People With HIV (NCT00602758) | University of Missouri, Kansas City | 2004-12-01 |
| Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection (NCT00097799) | Boehringer Ingelheim | 2004-12-01 |
| Effectiveness of Modafinil for Treating Fatigue in Adults With HIV/AIDS (NCT00118378) | New York State Psychiatric Institute | 2004-12-01 |
| Cellular Immune Responses to Hepatitis B Virus (HBV)- Longitudinal Follow up and Natural History (NCT00168194) | The Alfred | 2004-12-01 |
| Safety of and Immune Response to a Hepatitis B Virus Vaccine Given With a Booster (CpG7909 ODN) in HIV Infected and HIV Uninfected People (NCT00100633) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-12-01 |
| Community Mobilization, Mobile Testing, Same-Day Results, and Post-Test Support for HIV in Sub-Saharan Africa and Thailand (NCT00203749) | University of California, Los Angeles | 2004-12-01 |
| Study Evaluating Vaccine in Adults With HIV (NCT00195234) | Wyeth is now a wholly owned subsidiary of Pfizer | 2004-12-01 |
| Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects (NCT00098722) | ViiV Healthcare | 2004-12-01 |
| Efficacy, and Safety Study of Optimized Background Antiretroviral Regimen (OB) in Combination With Enfuvirtide in the Treatment-Experienced Participants With Human Immunodeficiency Virus-1 (HIV-1) Infection (NCT02733419) | Hoffmann-La Roche | 2004-12-01 |
| Cellulose Sulfate (CS) Gel and HIV in Nigeria (NCT00120770) | FHI 360 | 2004-11-01 |
| Pharmacokinetics of Efavirenz in HIV-1 Infected Subjects With Hepatic Impairment (NCT00162097) | Bristol-Myers Squibb | 2004-11-01 |
| Antiretroviral Treatment Simplification Study With Efavirenz + Abacavir + 3TC Once Daily (NCT00314626) | Germans Trias i Pujol Hospital | 2004-11-01 |
| Seronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kaletra and Combivir® in HIV-Negative Healthy Subjects (NCT00192621) | Kirby Institute | 2004-11-01 |
| Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects (NCT00098306) | ViiV Healthcare | 2004-11-01 |
| Safety and Activity of the Oral HIV Entry Inhibitor AMD11070 in HIV Infected Patients (NCT00089466) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-11-01 |
| Durability of Nevirapine-Based Antiretroviral Regimen (NCT00703898) | Bamrasnaradura Infectious Diseases Institute | 2004-11-01 |
| Voluntary HIV Counseling, Testing, and Medication for Pregnant Women to Prevent Mother-to-Child HIV Transmission (NCT00084045) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-11-01 |
| Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of Antiretroviral-Experienced NonCCR5-Tropic HIV-1 Infected Subjects (NCT00098748) | ViiV Healthcare | 2004-11-01 |
| A 48-Week, Randomised, Study to Describe the Pharmacokinetic Profile and Durability of Atazanavir-Saquinavir-Ritonavir Once Daily and Describe the Pharmacokinetic Profile of Saquinavir-Ritonavir Using Saquinavir 500mg Formulation: the ASK-500 Study (NCT00192608) | Kirby Institute | 2004-11-01 |
| Study of Limited Versus Continuous Isoniazid Tuberculosis Preventive Therapy in HIV-infected Persons in Botswana (NCT00164281) | Centers for Disease Control and Prevention | 2004-11-01 |
| Optimizing Antiretroviral Therapy in HIV-Infected Children and Adolescents (NCT00207948) | Children's National Research Institute | 2004-11-01 |
| Friendship Based HIV/STI (Sexually Transmitted Infections) Intervention for African American Females (NCT00109421) | University of North Carolina, Chapel Hill | 2004-11-01 |
| Investigation of V520 in an HIV Vaccine Proof-of-Concept Study (V520-023) (NCT00095576) | Merck Sharp & Dohme LLC | 2004-11-01 |
| Safety of and Immune Response to an HIV-1 Subtype C Vaccine (AVX101) in HIV Uninfected Adults (NCT00097838) | AlphaVax, Inc. | 2004-10-01 |
| Tenofovir DF (Disoproxil Fumarate) in Combination With Emtricitabine in HIV-1 Patients (NCT00106379) | Gilead Sciences | 2004-10-01 |
| HIV Assessment in Fuyang, Anhui Province, China (NCT00094354) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-10-01 |
| Efficacy of Alendronate Versus Placebo in the Treatment of HIV-associated Osteoporosis (ANRS120) (NCT00120757) | French National Agency for Research on AIDS and Viral Hepatitis | 2004-10-01 |
| Anti-HIV Drugs for Ugandan Patients With HIV and Tuberculosis (NCT00078247) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-10-01 |
| HIV Risk Reduction and Drug Abuse Treatment in Iran (NCT00398008) | Yale University | 2004-10-01 |
| Engagement in HIV Primary Care Services (NCT00300170) | Montefiore Medical Center | 2004-10-01 |
| SWEET: Once Daily Truvada Versus Twice Daily Combivir for the Treatment of HIV Infection (NCT00323544) | Gilead Sciences | 2004-10-01 |
| Effect of HIV/STD Risk Reduction Program on South African Adolescents (NCT00559403) | University of Pennsylvania | 2004-10-01 |
| Feasibility Study of a Vaginal Ring for Delivery of TMC120 (Dapivirine) (NCT00700284) | International Partnership for Microbicides, Inc. | 2004-10-01 |
| Lay Health Advisors for Sexually Transmitted Disease Prevention (NCT00207506) | Centers for Disease Control and Prevention | 2004-10-01 |
| Safety of and Immune Response to Two HIV Vaccine Formulations (rMVA-HIV and rFPV-HIV) Alone or in Combination in HIV Uninfected Adults (NCT00083603) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-09-01 |
| An Affect Management Intervention for Juvenile Offenders (NCT00748800) | Rhode Island Hospital | 2004-09-01 |
| HIV Risk Reduction in Youth in the Bahamas (NCT00774592) | Wayne State University | 2004-09-01 |
| AIDS Vaccine Study Comparing Immunogenicity and Safety of 3 Doses of Lipopeptides Versus Placebo in Non Infected HIV Volunteers (NCT00121758) | French National Agency for Research on AIDS and Viral Hepatitis | 2004-09-01 |
| Effect of HIV Protease Inhibitor Drugs on Glucose and Insulin Metabolism (NCT00135434) | Bristol-Myers Squibb | 2004-09-01 |
| Combination of Efavirenz and Truvada - COMET Study (NCT00224458) | Gilead Sciences | 2004-09-01 |
| Prevalence of Proteinuria and Chronic Kidney Disease in Pediatric HIV-Infected Patients (NCT00153621) | Children's National Research Institute | 2004-09-01 |
| Role of Positive Affect in Adjustment to HIV (NCT00582023) | University of California, San Francisco | 2004-09-01 |
| A Study of Prevalence of the I50L Mutation When ATV Treated Patients Fail the Regimen (NCT00135447) | Bristol-Myers Squibb | 2004-09-01 |
| Study Comparing Racivir and Lamivudine in Treatment-Experienced HIV Subjects (NCT00121979) | Pharmasset | 2004-09-01 |
| Retrovirus Epidemiology Donor Study-II (REDS-II) (NCT00097006) | National Heart, Lung, and Blood Institute (NHLBI) | 2004-09-01 |
| Trial of SAVVY Vaginal Gel and HIV in Nigeria (NCT00130078) | Biosyn | 2004-09-01 |
| Efficacy and Safety of PegIFN +/- FTC / TDF to Treat Chronic Hepatitis B in HIV-Coinfected Patients (NCT00221286) | University Hospital, Bonn | 2004-09-01 |
| Brief Introductory Therapy for Opioid Dependence (NCT00406484) | Yale University | 2004-09-01 |
| A Phase I Study of Safety and Immunogenicity of the WRAIR HIV-1 Vaccine (NCT00412477) | U.S. Army Medical Research and Development Command | 2004-08-20 |
| Candidate HIV Vaccine (NCT00089531) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-08-02 |
| Effect of Atazanavir on Endothelial Function in HIV-Infected Patients (NCT00447070) | Foundation for Cardiovascular Research, Zurich | 2004-08-01 |
| Long-term Effects of Highly Active Anti-Retroviral Therapy on HIV-Infected Children (NCT00260806) | University of Miami | 2004-08-01 |
| Study to Evaluate the Replacement of Reverse Transcriptase Nucleoside/Nucleotide Inhibitors by Nevirapine in Patients on Triple Treatment With Analogues Only (NCT00415090) | Hospital de Calella | 2004-08-01 |
| Lopinavir/r Monotherapy as Maintenance Therapy After Long Term Viral Suppression (NCT00160849) | Universidade Federal do Rio de Janeiro | 2004-08-01 |
| Assessment of Cytokine Values in Serum and by RT-PCR in HIV-1 Individuals With and Without HAART (NCT00746473) | UPECLIN HC FM Botucatu Unesp | 2004-08-01 |
| ADAPT-POL New Orleans: Adaptation of Prevention Techniques With Popular Opinion Leader (NCT00252109) | Centers for Disease Control and Prevention | 2004-07-01 |
| Safety of Intradermal Versus Intramuscular Administration of HIV Lipopeptides in HIV Uninfected Adult Volunteers (NCT00121121) | French National Agency for Research on AIDS and Viral Hepatitis | 2004-07-01 |
| Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV) (NCT00078403) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-07-01 |